BioLineRx (BLRX) Notes Payables (2011 - 2018)

BioLineRx's (BLRX) quarterly Notes Payables came in at $93000.0 in Q3 2018, little changed year-on-year from $93000.0 in Q3 2017, and little changed quarter-over-quarter from $93000.0 in Q2 2018.

BioLineRx (BLRX) Notes Payables (2011 - 2018) Analysis & Trends

BioLineRx's Notes Payables history runs 7 years deep, the most recent figure standing at $93000.0 for Q3 2018.

  • On a quarterly basis, Notes Payables changed 0.0% year-over-year to $93000.0 in Q3 2018; TTM through Sep 2018 was $93000.0, a 0.0% change from a year earlier, with the FY2017 full-year figure at $93000.0, changed 0.0% from the prior year.
  • Notes Payables was little changed at $93000.0 in Q3 2018 per BLRX's latest filing, from $93000.0 in the prior quarter.
  • Across five years, Notes Payables topped out at $93000.0 in Q3 2015 and bottomed at $93000.0 in Q3 2015.
  • The 4-year median for Notes Payables is $93000.0 (2015), against an average of $93000.0.
  • Biggest YoY gain for Notes Payables was 0.0% in 2016; the steepest drop was 0.0% in 2016.
  • Year by year, Notes Payables stood at $93000.0 in 2015, then changed by 0.0% to $93000.0 in 2016, then changed by 0.0% to $93000.0 in 2017, then changed by 0.0% to $93000.0 in 2018.
  • Per Business Quant, the three latest BLRX Notes Payables figures stand at $93000.0 (Q3 2018), $93000.0 (Q2 2018), and $93000.0 (Q1 2018).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn -
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn
4 NuCana 279.75 Bn 279.75 Bn -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn
7 Belite Bio 62.51 Bn 62.51 Bn -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn
9 Revolution Medicines 37.78 Bn 37.78 Bn -
10 BioLineRx 7.05 Bn 7.06 Bn 154,000.00

Historic Data

Download Data
DateValue
Sep 30, 2018 93,000.00
Jun 30, 2018 93,000.00
Mar 31, 2018 93,000.00
Dec 31, 2017 93,000.00
Sep 30, 2017 93,000.00
Jun 30, 2017 93,000.00
Mar 31, 2017 93,000.00
Dec 31, 2016 93,000.00
Sep 30, 2016 93,000.00
Jun 30, 2016 93,000.00
Mar 31, 2016 93,000.00
Dec 31, 2015 93,000.00
Sep 30, 2015 93,000.00
Mar 31, 2013 15,000.00
Dec 31, 2012 37,000.00
Sep 30, 2011 83,000.00